Annual Report

Overview

The report describes the group's 2020 performance, including revenue of RMB1,594,897 RMB'000 and continued expansion of its biopharmaceutical pipeline. It reports 2,453 employees, energy consumption of 61,578.49 MWh and no work-related fatalities. The ESG section also describes Board responsibility for ESG oversight and a materiality-matrix process.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Publication date: 30 March 2021
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services